Received Mar 16, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 4L454 | — |
received an incomplete dose of Kinrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete dose administered in a 4-year-old male patient who received DTPa-IPV (Kinrix) (batch number 4L454) for prophylaxis. On 10-MAR-2026, the patient received Kinrix. On 10-MAR-2026, an unknown time after receiving Kinrix, the patient experienced incomplete dose administered (Verbatim: received an incomplete dose of Kinrix). The outcome of the incomplete dose administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 11-MAR-2026 The other health professional called and reported that the 4 years of age patient received an incomplete dose of Kinrix, the patient moved his arm while the professional was administering the product.